Neurogene (NASDAQ:NGNE) Price Target Raised to $22.00
Neurogene (NASDAQ:NGNE – Free Report) had its price objective hoisted by BMO Capital Markets from $16.00 to $22.00 in a report released on Tuesday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock. Other equities research analysts also recently issued research reports about the stock. Baird R W downgraded shares of Neurogene […]
Neurogene (NASDAQ:NGNE – Free Report) had its price objective hoisted by BMO Capital Markets from $16.00 to $22.00 in a report released on Tuesday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock. Other equities research analysts also recently issued research reports about the stock. Baird R W downgraded shares of Neurogene […]
